Paul Rosenau

Telefoonnummer: +316-86 87 72 20
E-mailadres: p.rosenau@accare.nl

Paul has been a researcher at Accare since 2017.

Biography

Paul studied clinical neuropsychology at the University of Groningen. For his dissertation, he investigated whether implementing a trial discontinuation during the treatment of ADHD symptoms with methylphenidate is an effective way to evaluate whether the medication still benefits the child. After one year, many children may enefit from a dosage review or may even be able to stop the medication. There is a need to develop a practical and systematic method to evaluate treatment with methylphenidate and to assist in creating personalized treatment plans. He now works as a postdoctoral researcher on several projects.

Paul Rosenau

Biography

Published on date

Published in

Published on date

Published in

Published on date

Published in

Published on date

Published in

Biography

Research studies

MASK

Methylphenidate: trial of discontinuation

Publications

ADHD medication adherence reduces risk of committing minor offenses in adolescents

Published on date

Published in

Adherence to Clinical Guidelines for Dose Finding and Monitoring Methylphenidate Use: A Medical Record Audit in Child and Adolescent Mental Health Care and Pediatric Settings

Published on date

Published in

Withdrawing methylphenidate in relation to serum levels of ferritin and zinc in children and adolescents with attention-deficit/hyperactivity disorder

Published on date

Published in

Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study

Published on date

Published in